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Introduction: Atrial switch surgery, previously the intervention of choice for transposition of the great arteries, has
been superseded by the arterial switch operation. The cohorts of patients who received atrial switch operations
remain at risk of complications including sudden cardiac death, heart failure, and arrhythmias and require life-
long monitoring. The American Heart Association issued guidance in 2018 about how follow up should be un-
dertaken. We sought to compare the follow up regime suggested by these, and the European Society of Cardiology
guidelines to the reality of that achieved in a specialist ACHD centre.
Methods: Patients under follow up after atrial switch surgery at a Level 1 centre were identified; demographic and
clinical data were collected. Timeframes of follow up were compared to those suggested by the guidelines.
Results: We identified 110 patients following atrial switch surgery. At the end of the study period 94 patients
(median age 41, IQR 11), remained under follow up. There were 16 patients whom had either died or undergone
transplantation. Over two-thirds (65,69%) received a specialist clinic review within the recommended timeframe.
Almost one fifth, 17 patients (18%) underwent cardiac magnetic resonance imaging within the recommended
timeframe.
Conclusion: Our results show that achieving the recommended timeframes for patient follow up following atrial
switch surgery is challenging in real life clinical practice. Future studies are needed to provide evidence for
optimal follow up intervals that result in improvements in patient outcomes, given the cost and resource impli-
cations of these enhanced follow up regimes.1. Introduction
Transposition of the great arteries is characterised by atrioventricular
concordance and ventriculoarterial discordance. It was first described in
1797 and conferred a dismal prognosis until the mid-twentieth century,
when atrial switch surgical techniques were developed by Senning and
Mustard to palliate this defect [1–3]. Concerns over the long term
sequelae of these techniques led to atrial switch surgery being superseded
by the arterial switch operation [4,5].
Atrial switch procedures confer a lifelong risk of complications. Sys-
temic right ventricles are prone to dysfunction, ultimately resulting in
heart failure, with this incidence increasing in each decade of life
following the atrial switch procedure [6–8]. A meta-analysis bycts of the reliability and freedom
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vier B.V. This is an open access arVenkatesh et al. found approximately one-fifth of deaths in atrial switch
patients were due to congestive cardiac failure [6]. Heavy atrial scarring
sustained through the surgical construction of baffles predisposes these
patients to arrhythmias, affecting 60% of patients 20 years after surgery
[6,7]. Other significant sequelae are baffle leaks and baffle stenosis.
Baffle leaks are commonly seen in the long-term follow up of these pa-
tients and are an important risk factor for paradoxical strokes [9]. Baffle
obstruction can cause a variety of complications including superior vena
cava syndrome, hepatic cirrhosis and pulmonary hypertension [7,9].
Pulmonary hypertension is a finding of concern in atrial switch patients,
and although baffle stenoses are a cause of pathologically elevated pul-
monary arterial pressures, the aetiology of pulmonary hypertension in
the vast majority of these patients is not yet fully understood [7,10]. Thefrom bias of the data presented and their discussed interpretation.
March 2021
ticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
J. Williams et al. International Journal of Cardiology Congenital Heart Disease 3 (2021) 100123turbulent flow in these structurally altered hearts means patients are at
an increased risk of infective endocarditis [11]. Systemic atrioventricular
valve regurgitation (morphological tricuspid valve) is known to occur in
this group of patients, though it does not typically cause additional
complications such as heart failure [6,12].
The most serious complication for patients following atrial switch
surgery is that of sudden cardiac death (SCD). SCD is the commonest
cause of late post-surgical mortality in these patients [6]. Furthermore,
patients with atrial switch repairs for transposition of the great arteries
have some of the highest rates of SCD amongst all patients with
congenital heart disease [13]. The risk of SCD has been shown to be
strongly predicted by the presence of supraventricular tachyarrhythmias
[14]. Therefore identification of arrhythmic events in this cohort of pa-
tients during follow up is important.
In 2018 the American Heart Association (AHA) published guidance
on the management of Adults with Congenital Heart Disease (ACHD).
These guidelines stipulate the type and frequency of follow up for pa-
tients who have received atrial switch surgery [15]. The suggested as-
pects of follow up are outpatient ACHD specialist review,
electrocardiogram, echocardiogram, pulse oximetry, Holter monitoring,
cardiac magnetic resonance imaging and cardiopulmonary exercise
testing. The frequency of follow up is varied according to a novel ACHD
anatomical and physiological grading system. Transposition of the great
arteries is classed as anatomical complexity grade III (the highest), and
the physiological stage is classed from A to D depending on various
subjective and objective clinical parameters, with the highest score
determining a patient's physiological stage.
In 2020 the European Society of Cardiology (ESC) updated guidance
on the management of patients with congenital heart disease, providing
recommendations for the follow up of patients with Senning andMustard
repairs for transposition of the great arteries [16]. The ESC and AHA
guidance differ in that the ESC guidance does not use a physiological
staging system, nor a rigid timeline of follow up frequency. ESC guidance
discusses the serious and frequently occurring complications in Senning
and Mustard patients and advises clinicians on how best to approach and
investigate these sequelae, with particular reference to the common
pitfalls in standard cardiac imaging modalities in detecting subtle
changes in atrial switch physiology. The clinical utility of quantitative
exercise testing in assessing cardiac symptoms and function is emphas-
ised, rather than relying on subjective reporting of exercise tolerance
which may be falsely reassuring. The prognostic importance of late
gadolinium enhancement on magnetic resonance imaging is also high-
lighted. Additionally the challenges of diagnosing pulmonary hyperten-
sion are addressed and a low threshold for cardiac catheterisation is
suggested [15,16].
We sought to compare the ‘real-world’ follow up of our patients based
at the level 1 ACHD Centre at University Hospitals Birmingham (UHB)
against the specific regime recommended by the American Heart Asso-
ciation and European Society of Cardiology guidelines.
2. Methods
2.1. Patient cohort and data collection
Adult patients who had undergone either a Mustard or Senning pro-
cedure for transposition of the great arteries who were under follow up at
the level 1 ACHD Centre, Queen Elizabeth Hospital, University Hospitals
Birmingham were identified. This study was registered and approved by
the hospital's Clinical Audits and Registries Management Service
(CARMS) (reference 15080).
Patient information was collected from electronic patient records
betweenMarch to October 2019. Patient demographic data was collected
including age, gender, age at time of atrial switch surgery and current
medications. Catheter ablation for arrhythmia and heart transplantation
were noted if present. Other data were collected to allow comparison to
the AHA guidelines, these included details of their last outpatient review,2
electrocardiogram results, pulse oximetry readings, Holter monitor/de-
vice interrogation results, and cardiopulmonary exercise test results.
Imaging reports from echocardiographic studies and magnetic resonance
examinations were also recorded. Where multiple results were available
for the same investigation, only the most recent result was documented.
Mortality data and data regarding the presence or absence of complica-
tions such as baffle leaks, were collected to determine the outcomes of
our patients compared to those suggested by the ESC guidelines.
2.2. Statistical methods
Data were collected and analysed using a data collection tool con-
structed on Microsoft Excel 2020 (Microsoft, Washington) and further
analyses were conducted using SPSS 2020 (IBM, New York). The Shapiro-
Wilk test of normality was utilised in SPSS to determine which data were
parametric (presented in the text as mean SD) and which data were
non-parametric (presented as median (interquartile range)).
2.3. Echocardiography methods
Echocardiograms were undertaken using standard ultrasound equip-
ment (Philips iE33 Medical Systems, The Netherlands). Right ventricular
dilatation was noted and right ventricular function was graded by
echocardiogram using a range of imaging parameters, including experi-
enced operator visual assessment, fractional area change (<35% defined
as abnormal) and tissue Doppler derived tricuspid lateral annular systolic
velocity (S’<10 defined as abnormal), in accordance with American
Society of Echocardiography guidelines [17]. Function was then graded
as normal, mildly impaired, moderately impaired, and severely impaired
according to these parameters.
2.4. Cardiac magnetic resonance imaging
Cardiac Magnetic Resonance (CMR) imaging was performed using a
1.5 T scanner (Magnetom Avanto, Siemens, Germany). Cardiac
morphology and function were studied using standard CMR protocols,
with steady state free precession cine images. Typical imaging parame-
ters were temporal resolution 40–50msec, repetition time 3.2 msec, echo
time 1.7 msec, flip angle 60ᵒ, field of view 300mm, spatial resolution
1.5 1.5mm2, slice thickness 7mm with 3mm gap and minimum 25
phases per cardiac cycle in accordance with previously validated meth-
odology [18]. Image analysis was performed off-line using cvi42 (Circle
Vascular Imaging, Calgary, Canada). Ventricular volumes and function
were calculated from standard contouring of the ventricular short axis
stack in end diastole and end systole, as per Biobank protocols [18].
2.5. Comparison of follow up regime compared to guideline
recommendations
AHA guidelines suggest that frequencies of each aspect of follow up
are based upon each patient's physiological stage. Patients were classified
into physiological stage (A to D) as per the AHA guidelines, and New
York Heart Association functional class based on the demographic and
clinical data collected from their patient records [15]. For each patient
the time period between their most recent follow up and date of data
collection was calculated for each aspect of their follow up regime. This
time interval was then compared to those recommended by the AHA
guidelines for their physiological stage to see whether the recommen-
dations had been met. Comparison was also made with ESC Guidelines.
3. Results
3.1. Patient cohort demographics
One hundred and ten patients with previous Senning or Mustard
operations who were, or had been under active follow up prior to death
Table 2
Echocardiographic and cardiac magnetic resonance imaging data [29].
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patients had received a heart transplant. One of the patients who received
a heart transplant died. Of the patients who did not receive a heart
transplant, eleven had died.
Of those who died, 5 were in physiological Class C, and 6 in Class D.
For those patients who underwent transplantation, 2 were Class C and 3
were Class D (including the one who died). Therefore 94 patients with a
systemic right ventricle remained under follow up by the adult congenital
heart team; adherence to timeframes suggested by AHA guidelines are
presented for these 94 patients only. Of these 94 patients, 56 patients
were male (60%). Themedian age of patients still alive at the time of data
collection was 41 years (IQR: 11), ranging from 28 to 56 years old.
The majority of patients had undergone a previous Mustard proced-
ure (59 patients, 63%) compared to a Senning procedure (35 patients,
37%). Fifty-four of these patients (57%) had the operation within the first
year of life.
Results for NYHA class and AP physiological stage are given in
Table 1. The majority of patients were in NYHA Class I (66 patients,
70%), whilst not one patient was Class IV. For the AP physiological stage
classification, most patients were stage C (71 patients, 76%), followed by
stage B (21 patients, 22%) and then stage D (2 patients, 2%). No patients
were in Stage A. A Stage C classification was mainly due to either mod-
erate or greater ventricular dysfunction, or arrhythmias controlled with
treatment. Catheter ablation for arrhythmia had been performed in 27
patients (29%). The majority of patients (n¼ 60, 64%), were prescribed
at least one cardiac medication. Of the patients prescribed medications,
43 patients (46%) were prescribed beta blockers, 32 patients (34%)
angiotensin-converting enzyme (ACE) inhibitors, 35 patients (37%) were
prescribed either warfarin or a direct oral anticoagulant, and 22 patients
(23%) were prescribed a diuretic.
3.2. Outpatient clinic appointments
For the 94 patients alive and continuing with follow up, 65 (69%) had
received a clinic review within the timeframe for their physiological
stage as recommended by the AHA guidelines.
3.3. Electrocardiogram
Fifty six patients (60%) had an electrocardiogram recorded within the
timeframe recommended for their physiological stage. For 90 patients an
ECG at some point over the course of their follow up was available for
rhythm interpretation, or a summary of the ECG rhythm was recorded inTable 1
Clinical status of atrial switch patients, electrocardiogram and pulse oximetry
results.
NYHA status (n¼ 94)
Class I, n (%) 66 (70)
Class II, n (%) 20 (21)
Class III, n (%) 8 (9)
Class IV, n (%) 0 (0)
AP Physiological stage (n¼94)
A, n (%) 0 (0)
B, n (%) 21 (22)
C, n (%) 71 (76)
D, n (%) 2 (2)
ECG rhythm (n¼90)
Sinus, n (%) 65 (72)
Paced, n (%) 19 (21)
Abnormal atrial focus, n (%) 6 (7)
Pulse oximetry oxygen saturations (n¼83)
>94%, n (%) 69 (83)
91–94%, n (%) 11 (13)
88–90%, n (%) 1 (1)
<87%, n (%) 2 (2)
NYHA stands for New York Heart Association; AP, anatomical/physiological;
ECG, electrocardiogram.
3
a clinic letter, see Table 1. 65 patients (69%) were in sinus rhythm. The
ECG for six patients demonstrated either atrial tachycardia or atrial
flutter. Conduction abnormalities could be assessed for 83 patients,
whilst cardiac axis could be assessed for 80 patients. A right bundle
branch block pattern was present for 46 patients (49%) and a left bundle
branch block in 2 patients (2%). Widespread T-wave inversion was
present in the ECGs of 35 patients (37%). The majority of ECGs
demonstrated right axis deviation (n¼ 64, 68%), followed by a normal
axis (n¼ 11, 12%), whilst left axis deviation was found the least (n¼ 5,
5%). PR interval duration could be assessed for 80 patients, of these 15
patients (16%) had a PR interval greater than 200msec.
3.4. Transthoracic echocardiogram
Of the 94 patients with ongoing follow up, 54 (57%) had a trans-
thoracic echocardiogram within the timeframe recommended by their
physiological stage. A full echocardiography report was available for 87
patients. Sixty five (69%) patients were noted to have significantly
dilated systemic right ventricles. Systemic ventricular function was most
commonly mildly impaired (n¼ 41, 44%) and severely impaired in 12
patients (13%). The degree of tricuspid regurgitation most frequently
seen was mild (n¼ 42, 45%), see Table 2. Three patients (3%) had a
baffle leak noted on their most recent echocardiogram.
3.5. Pulse oximetry
Fifty eight patients (62%) had their pulse oximetry documented
within the stipulated timeframe for their physiological stage. Results of
pulse oximetry were available for 83 patients, the majority of patients
(n¼ 69, 73%) had saturations above 94%, see Table 1.
3.6. Holter monitoring
Thirty three patients (35%) of the ninety four with ongoing follow up











Cardiovascular Magnetic Resonance data (n¼55)
Parameter Median(IQR)/
Mean±SD






Stroke volume (ml) 91± 26









Stroke volume (ml) 70± 21
Ejection fraction (%) 62± 11
Data presented as mean±SD or median(IQR). SD, standard deviation; IQR, inter-
quartile range.
Table 3
Number and percentage of patients meeting follow-up criteria for each physio-
logical stage.
Physiological stage: N (%)
A (n¼ 0) B (n¼ 21) C (n¼ 71) D (n¼ 2)
OP Clinic – 9 (43) 54 (76) 2 (100)
ECG – 7 (33) 47 (66) 2 (100)
TTE – 11 (52) 41 (58) 2 (100)
Pulse oximetry – 9 (43) 47 (66) 2 (100)
Holter – 2 (9.5) 31 (44) 0 (0)
CMR – 6 (29) 11 (15) 0 (0)
CPEX – 8 (38) 32 (45) 1 (50)
OP: outpatient; ECG: electrocardiogram; TTE: transthoracic echocardiogram;
CMR: cardiac magnetic resonance; CPEX: cardio-pulmonary exercise test.
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patients the ambulatory recording was with a Holter monitor, the other
25 patients had a device in situ that could be interrogated for any rhythm
disturbances. Six patients had an intra-cardiac defibrillator (ICD), five
had a Reveal device and fourteen had a pacemaker.
Ambulatory ECG monitoring results conducted at any point in the
past were available for 67 patients in total. 41 patients (44%) had a
Holter monitor report. 5 patients had a Reveal device in situ. 21 patients
had a permanent cardiac device in situ (6 ICD; 15 pacemakers) capable of
detecting and recording rhythm abnormalities.
Four patients were noted to have a mean heart rate lower than 60
bpm, whilst eight patients had episodes of non-sustained ventricular
tachycardia detected on their ambulatory ECG recording.
3.7. Cardiac magnetic resonance imaging
In our cohort of 94 patients, 21 (22%) had either an ICD or a per-
manent pacemaker in situ. These patients were deemed to have been
ineligible for CMR due to the potential contraindication of their cardiac
device. By excluding these 21 patients from the 94 under follow up, 73
patients could have undergone CMR. Seventeen of these 73 patients
(23%) had a documented CMR studywithin the timeframe recommended
for their physiological stage. Fifty-five patients of the 73 patients without
a device (75%) had undergone at least one CMR study during their follow
up. The volumetric results for these studies are summarised in Table 2. A
baffle leak was identified on CMR in seven patients. Of the 21 patients
that had either an ICD or a permanent pacemaker, 8 patients previously
had a CMR study at some point in the past. This means that in our overall
figure of 94 patients, 63 (67%) had undergone at least one CMR study
during follow up.
In the 17 patients with a CMR study within the timeframe recom-
mended by the AHA for their physiological stage, 10 patients (59%) also
received an echocardiogram within the recommended timeframe, and 11
patients (65%) received an exercise test within the recommended
timeframe.
Conversely, in the remaining 56 patients that did not receive a CMR
within the timeframe recommended by the AHA for their physiological
stage, 44 patients (79%) received an echocardiogram within the rec-
ommended timeframe, and 30 patients (54%) received an exercise test
within the recommended timeframe. Eleven patients had undergone late
gadolinium enhancement as part of a CMR examination. None of these
had any visible areas of late gadolinium enhancement within their sys-
temic right ventricle.
3.8. Exercise test
Forty one of the patients (44%) with ongoing follow up had under-
taken an exercise test within the recommended timeframe for their
physiological stage. For the majority of patients (39 patients), this was in
the form of a cardiopulmonary exercise test, 2 patients undertook a
shuttle test.
Results from an exercise test were available in 73 patients (78%). Of
these, 71 had undertaken a standardised ramped protocol cardiopulmo-
nary exercise test. The mean duration of exercise was 8min 58 s with a
standard deviation of 2min 40 s. The median peak VO2 was 22.6ml/kg/
min (IQR: 7.6ml/kg/min). The mean VE/VCO2 slope was 34± 6, range
22–48.
3.9. Overall adherence to guideline timeframes and relationship to
physiological staging
Of the ninety four patients remaining under follow up, ten had un-
dergone all seven follow up procedures within the timeframe recom-
mended by the AHA guidelines for their physiological stage. Eighteen
patients had undergone four aspects of the follow up regime, whilst
another 16 had completed five aspects of the follow up regime. Of the4
remaining patients, 14 had not had any part of their follow up regime
within the recommended timeframe, whilst 6 had one aspect, 9 had two
aspects, 9 had three aspects and the remaining 12 had completed six
follow up procedures in the timeframe suggested by the AHA guidelines.
Each physiological stage subgroup (A-D) was examined for its indi-
vidual adherence to AHA timeframe recommendations for follow-up. Full
results for this can be seen in Table 3. As patients moved into progres-
sively more ‘severe’ physiological stages, adherence to each aspect of
follow-up increased. The exception was CMR, which was more
commonly used in physiological stage ‘B’ patients than stage ‘C’.
4. Discussion
Our results show that achieving the recommended guideline time-
frames for follow up of patients following atrial switch surgery is chal-
lenging in real life clinical practice. We found that the best adherence to
the guidelines was for outpatient clinic review and the worst for cardiac
magnetic resonance imaging frequency.
4.1. Adherence to guideline timeframes
4.11. Outpatient clinic appointments
In our population of atrial switch patients, over two thirds had a
completed outpatient specialist ACHD review within the recommended
guideline timeframe for their physiological stage. Maintaining regular
clinic reviews with a dedicated ACHD specialist team is a crucial aspect of
the lifelong care these patients require. We noted that many patients did
not attend appointments that had been scheduled and this was why
follow up had failed to occur in a timely manner. These patients are likely
to be affected by working lives and looking after young families. Addi-
tionally, it may be that if they feel well they may choose to extend the
time between clinic appointments by rescheduling themselves [19].
4.12. Cardiac investigations
The investigation that was least frequently conducted within the
appropriate timeframe according to AHA guidelines was cardiac mag-
netic resonance (CMR) imaging. 21 patients had a cardiac device that
posed a potential contraindication to CMR imaging. ESC guidance
regarding care of patients with congenital heart disease states that ACHD
patients with implanted cardiac devices should receive CMR in-
vestigations, provided the device is MR conditional and appropriate
support is available [16,20]. However the diagnostic value of CMR
studies in patients with devices may be significantly impaired by artefact
[21,22]. Additionally CMR is not universally tolerated due to claustro-
phobia. Compared to other aspects of follow up recommended by AHA
guidelines, CMR is the most expensive to perform and in a publicly
funded health care system is usually utilised when there is a clinical
change to suggest the need for a further study, rather than as routine
surveillance at a fixed time point, especially if adequate imaging can be
obtained with transthoracic echocardiography. Echocardiography was
performed more frequently, according to the timeframes suggested by
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more of a gatekeeper to CMR. In our patients that did not receive a CMR
within their recommended timeframe, slightly more patients (79%)
received an echocardiogram than those that did receive a CMR within
their timeframe (59%), suggesting that possibly either an echocardio-
gram alone was seen as sufficient imaging during a follow up encounter,
or that an additional echocardiogram was not deemed necessary
following a CMR study.
AHA guidance for atrial switch patients states that where CMR is not
available, Cardiovascular Computed Tomography (CCT) can be used in
its place [15]. However, serial use of CCT constitutes a significant radi-
ation exposure and increased future risk of malignancy in a relatively
young patient population such as ours.
Performing more frequent CMR studies for our atrial switch patients
is an area for improvement in our centre, as although there are health
economic factors to consider in utilising costly investigations as
mentioned above, the use of CMR can be of critical importance in a pa-
tient with complex congenital heart disease [23]. As ESC guidance rec-
ommends, CMR can be not only of diagnostic value for assessing
complications following atrial switch surgery, but also an important step
prior to interventional or electrophysiological procedures which are
often required in these patients [16].
In the follow up of our atrial switch patients 44% had undergone a
formal exercise test within the recommended AHA timeframe. Exercise
testing forms a critical part of the follow up of atrial switch patients for
several reasons. Firstly, there is strong evidence to correlate exercise test
performance with prognosis in congenital heart disease patients [24].
Furthermore, it is recognised in patients with congenital heart disease
that self-reported exercise tolerance poorly reflects true cardiovascular
function, stemming from lifelong physical and psychological adaptations
these patients make to their condition [25].
4.2. Classification of patients according to physiological stage grading
Follow up procedure frequency is varied according to a novel
anatomical/physiological grading system piloted by the 2018 American
Heart Association guidelines [15]. As such this grading system is rela-
tively new and not well validated for use in the long-term follow up of
these complex patients, although in adults with various ACHD conditions
it has been found to have better predictive power for early postoperative
mortality than existing scoring systems [26]. The aim of this grading
system was to capture the complexity of ACHD anatomy and physiology
that are not always correlated. Although the data selected for inclusion in
the anatomical/physiological grading system are known to confer
importance for prognosis, management or quality of life, this data is
across the whole spectrum of congenital conditions and not specific to
any one group. Given the relatively small proportion of patients who
have undergone atrial switch surgery compared to other congenital
conditions the relevance of a grading system that is derived from data in
other congenital conditions is uncertain. However the anatomical/phy-
siological grading system is likely to be of greater relevance compared to
grading systems that are derived from acquired heart disease data.
By including physiological variables as well as anatomical data the
aim is that the grading system will be able to reflect the dynamic nature
of managing patients with congenital heart disease that is not purely
dependent on the description of their anatomy. This, as per the guideline
would then result in an alteration in the frequency of monitoring, ac-
cording to the patient's changing clinical circumstances. The ACHD
grading system allows patients to move in either direction of severity
depending upon their current clinical condition.
The majority of our patients were classed as physiological stage C due
to either their ventricular dysfunction or treated arrhythmia. This man-
dates more frequent follow up procedures especially for Holter moni-
toring and magnetic resonance imaging than lower physiological classes.
The use of physiological stages to define various aspects of follow-up
mandates an assumption of a degree of uniformity in terms of clinical5
status and prognosis within each physiological stage. However, given the
complex nature of these atrial switch patients’ conditions and the range
of complications they experience, there likely exists significant vari-
ability within this group of patients sharing a physiological stage. Our
data support this notion, as half of the patients who died were in Class C
and not Class D, suggesting that further work is required to refine this
grading system for use in determining the prognosis and risk of mortality
in patients following atrial switch surgery.
Additionally we observed that as patients progressed through physi-
ological stages follow up adherence increased, likely reflecting that as
physiological parameters worsen and patients become more symptom-
atic, clinicians appropriately respond to these changes and investigate
patients with increasing frequency accordingly.
4.3. Evidence for guidelines
The level of evidence available to support the AHA guideline rec-
ommendations about follow up procedures/intervals following atrial
switch surgery is limited. The evidence level for Holter monitoring and
annual MRI or echocardiographic imaging is graded as expert opinion.
The time intervals for all procedures have been based on expert opinion.
There is no definitive evidence to suggest that outcomes are improved
because of an increased frequency of monitoring in patients with a higher
physiological stage. Therefore, for example, suggestions about whether
exercise tests should be conducted every year versus every three years
depending upon the physiological stage are arbitrary and not known to
alter outcomes despite imposing a large additional service burden.
However it is increasingly recognised that congenital heart disease
patients benefit from multi-modality imaging, which when used
together, may detect subclinical complications. In patients with complex
congenital heart disease it has been demonstrated that using other mo-
dalities of cardiovascular imaging (notably CMR) alongside echocardi-
ography provides the most effective and appropriate diagnostic
information in such complex patients and should be considered as stan-
dard care [27]. The additional cost of complementary imagingmodalities
may be offset by the avoidance of costly hospital admissions for heart
failure management. Future multi-centre registry data and studies will be
required to try and understand whether increased monitoring improves
patient outcomes in order to further target clinical resources to the areas
where they will have most benefit for patients.
4.4. Recommendations from ESC guidelines and areas for improvement
The 2020 guidelines from the European Society of Cardiology are not
prescriptive about timeframes regarding the follow up of atrial switch
patients [16]. Rather, they highlight important areas of follow up
including essential investigations and grant the clinician more autonomy
on when to use these tests. To this end it can be said that the follow up of
our atrial switch patients fulfilled the ESC guidelines more than the
chronological criteria proposed by the AHA. Indeed, the highly experi-
enced and specialist clinicians supervising the care of atrial switch pa-
tients will be aware of the fact that ‘one size does not fit all’ in such a
complex patient population and that guidelines should be there to sup-
plement and troubleshoot aspects of follow up rather than simply dictate
frequency of investigations without a broader oversight to the clinical
status of these patients.
In 2018 the European Heart Journal published guidance on cardio-
vascular imaging in congenital heart disease. This recommends a base-
line CMR in the transition from paediatric to adult populations and
proposes a 3-yearly interval between CMR studies for most ACHD pa-
tients with exceptions should clinical judgement suggest otherwise [27].
A proportion of our patients had never received a CMR, thus a baseline
CMR was not achieved, and all patients in the atrial switch cohort have
now reached adulthood. However, a 3-yearly interval between CMR
studies proposes a “happy medium” of sorts between ESC guidelines, that
do not suggest any specific timings for frequency of follow ups, and AHA
J. Williams et al. International Journal of Cardiology Congenital Heart Disease 3 (2021) 100123guidelines which could be seen as overly-rigorous for clinicians.
The predominant two areas identified in the follow up of our patients
that demonstrated a need for improvement were the frequency of CMR
studies and cardiopulmonary exercise tests. These have been widely
described in the literature as crucial for atrial switch patients and we
found that some patients in our cohort had not completed either one of
these tests. Whilst there may be valid reasons for this which have not
been recorded, it is important that all patients who have undergone atrial
switch procedures receive these objective investigations alongside
routine clinical review. Furthermore, the more extensive use of late
gadolinium enhancement on CMR could improve our risk stratification
for the risk of sudden cardiac death in our atrial switch patients as rec-
ognised in the literature [28].4.5. Limitations
This study is limited by the retrospective design and the absence of
some data for a proportion of patients. Additionally we are unable to
know if some patients have moved away from the area and are under-
taking their follow up in a different hospital. The study was conducted at
a single centre and therefore the applicability of these findings to other
centres will need to be considered. This work assessed clinical care
conducted in a country with publicly funded healthcare so the results
may not be applicable to a healthcare system where reimbursement oc-
curs for each clinical test and therefore more frequent tests may be
favoured.
5. Conclusions
In our large cohort of atrial switch patients we found that achieving
the recommended AHA guideline timeframes for follow up was chal-
lenging in real life clinical practice. We found the follow up of our patient
cohort was more suited to the less prescriptive guidance from ESC. The
best adherence to the guidelines was for specialist outpatient review and
the worst for cardiac magnetic resonance imaging frequency. This
highlights some areas for improvement in our follow up. Future studies
are required to support the use of the ACHD anatomical/physiological
classification to determine frequency of follow up procedures and
whether this has any effect on patient outcomes given the resource and
cost implications of these enhanced follow up regimes. Expert ACHD
clinician and multidisciplinary assessment is paramount for the long-
term follow up of these complex patients as is patient education about
the importance of life-long follow-up.
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